Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;47(5):708-12.
doi: 10.1093/rheumatology/ken079. Epub 2008 Apr 4.

Evaluation of a new algorithm in classification of systemic vasculitis

Affiliations

Evaluation of a new algorithm in classification of systemic vasculitis

L-J Liu et al. Rheumatology (Oxford). 2008 May.

Abstract

Objective: Recently, a new consensus algorithm for classification of ANCA-associated vasculitis (AAV) and PAN had been proposed by Watt et al. for epidemiological studies. In order to evaluate this algorithm, the current study used the algorithm to reclassify the patients with AAV and PAN in our centre.

Methods: Five hundred and fifty Chinese patients with primary systemic vasculitis diagnosed in our referral diagnostic centre during the past 10 years were retrospectively studied. Four hundred and ninety-three out of 550 were ANCA positive. We compared the new consensus algorithm and the 1994 Chapel Hill Consensus Conference (CHCC) definitions supplemented with surrogate parameters, in the same cohort of patients with primary systemic vasculitis.

Results: Applying the CHCC definitions with surrogate parameters, the diagnoses were Churg-Strauss syndrome (CSS) (n = 0), WG (n = 127), microscopic polyangiitis (MPA) (n = 363), PAN (n = 4) and unclassified (n = 56). Using the new consensus algorithm, the diagnoses were CSS (n = 2), WG (n = 199), MPA (n = 329), PAN (n = 0) and unclassified (n = 20).

Conclusions: Watts' algorithm was a useful method to classify patients into a single category, with less unclassified patients and without overlapping diagnosis, which allows their use in epidemiological studies.

PubMed Disclaimer

Publication types

Substances